Vinorelbine Injection Vinbicel

Product/Composition Vinorelbine Injection
Strength 10mg/1ml, 50mg/5ml
Form Injection
Production Capacity 10 Million Vials/Month
Packaging 1 Vial / Box
Therapeutic use Non-Small Cell Lung Cancer & Breast Cancer
Package Insert/Leaflet Available upon request
Brand Name Vinbicel

Vinorelbine Injection – Vinbicel is a cytotoxic anticancer medicine containing Vinorelbine, a semi-synthetic vinca alkaloid used in established chemotherapy regimens, particularly for non-small cell lung cancer (NSCLC) and advanced or metastatic breast cancer.

Vinorelbine acts primarily by binding to tubulin and inhibiting microtubule assembly. This disrupts mitosis and prevents susceptible cancer cells from dividing and multiplying.

Vinbicel is administered intravenously by qualified healthcare professionals under the supervision of an oncologist. The dosage and treatment schedule are determined according to the patient’s diagnosis, chemotherapy protocol, blood counts, organ function, and treatment response.

What is Vinorelbine?

Vinorelbine is a vinca alkaloid antineoplastic agent that interferes with microtubule formation during cell division. Its antimitotic activity helps inhibit the proliferation of rapidly dividing cancer cells.

It may be used as a single-agent treatment or in combination with other anticancer medicines depending on the cancer type and established treatment protocol.

Benefits / Uses

Vinorelbine Injection may be used for:

  • Non-small cell lung cancer (NSCLC)
  • Advanced or metastatic breast cancer
  • Selected solid tumors according to established oncology protocols
  • Combination chemotherapy regimens with other anticancer medicines

The specific indication and chemotherapy regimen should be determined by the treating oncologist.

Dosage Guidelines

Vinorelbine Injection is administered intravenously by qualified healthcare professionals.

  • The dose is determined according to the prescribed chemotherapy protocol and may be calculated based on body surface area.
  • Treatment is generally administered at scheduled intervals according to the selected regimen.
  • Complete blood counts should be monitored because neutropenia and other hematological toxicities can occur.
  • Dose modification or treatment interruption may be necessary in cases of significant toxicity or hepatic impairment.
  • Appropriate precautions should be taken during administration because extravasation may cause local tissue injury.

The exact dose and schedule should always follow the approved product information and oncologist’s instructions.

Wholesale & Supply

Vinbicel – Vinorelbine Injection can be supplied for hospitals, oncology centers, pharmaceutical distributors, wholesalers, and international healthcare markets, subject to applicable regulatory requirements.

Bulk pharmaceutical buyers can request:

  • Available strengths and presentations
  • Packaging configuration
  • Minimum order quantity
  • Production and supply capacity
  • Certificate of Analysis (CoA)
  • Product documentation
  • Regulatory and export documents

Buying Online

Vinorelbine is a prescription cytotoxic chemotherapy medicine and should only be procured through authorized pharmaceutical suppliers and used under qualified medical supervision.

Hospitals, licensed distributors, and healthcare procurement organizations can contact the supplier for product availability, commercial quotations, and applicable documentation.

Reviews

Individual responses to Vinorelbine-based chemotherapy can vary depending on the cancer type, disease stage, treatment combination, and patient characteristics. Treatment decisions should therefore be based on professional oncology assessment rather than individual product reviews.

Quality Assurance

Vinbicel should be manufactured and handled according to applicable pharmaceutical quality requirements. Quality-control testing for injectable products may include:

  • Identity and assay
  • Sterility
  • Purity and related substances
  • Appearance
  • Particulate matter
  • Container-closure integrity
  • Stability testing
  • Appropriate storage conditions

Product-specific quality and regulatory documentation can be provided upon request, where applicable.

Frequently Asked Questions

What is Vinbicel used for?

Vinbicel contains Vinorelbine and is used primarily in chemotherapy protocols for non-small cell lung cancer and advanced or metastatic breast cancer.

What type of medicine is Vinorelbine?

Vinorelbine is a semi-synthetic vinca alkaloid and cytotoxic antineoplastic medicine that inhibits microtubule formation during cell division.

How is Vinbicel Injection administered?

Vinbicel is administered intravenously by qualified healthcare professionals. Appropriate precautions are required during administration to reduce the risk of extravasation.

Is Vinorelbine used alone or with other medicines?

Vinorelbine may be administered either as a single agent or in combination with other anticancer medicines, depending on the specific cancer and treatment protocol.

What are the important side effects of Vinorelbine?

Potential adverse effects include neutropenia, anemia, nausea, constipation, fatigue, peripheral neuropathy, and injection-site reactions. Blood counts and other relevant clinical parameters should be monitored.

Does Vinbicel require specialist supervision?

Yes. Vinorelbine is a cytotoxic chemotherapy medicine and should be prescribed, prepared, administered, and monitored by appropriately trained healthcare professionals.

Conclusion

Vinbicel – Vinorelbine Injection is a vinca alkaloid anticancer medicine used in established chemotherapy protocols, particularly for non-small cell lung cancer and advanced breast cancer. Appropriate blood-count monitoring and professional intravenous administration are essential for safe use.